Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03472560
Title A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pfizer

lung non-small cell carcinoma

transitional cell carcinoma


Avelumab + Axitinib

Age Groups: adult | senior
Covered Countries USA | ITA | ESP

Additional content available in CKB BOOST